We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As part of its market study into exclusive pharmaceutical distribution contracts, the UK's Office of Fair Trading (OFT) could launch an investigation into Pfizer's wholesale distribution contract with Unichem.
As part of a Senate Finance Committee investigation, Sen. Chuck Grassley (R-Iowa) has requested information from Eli Lilly regarding the marketing of its antipsychotic drug Zyprexa.
Two Pfizer subsidiaries reached separate settlements with the U.S. government to address charges related to the marketing of the human growth hormone Genotropin, Pfizer announced.
Medical device companies "overwhelmingly" accept AdvaMed's Code of Ethics on Interactions with Health Care Professionals, but they face "significant challenges" in implementing the code, according to a white paper released last week.
Drug company spending on DTC advertising will continue to increase, although drugmakers are worried about potential legislation that would restrict the advertisements, research company Guideline said in a new report.
Canadian drugs sold to consumers in the U.S. via the internet last year were half what they were the year before, according to IMS Health researchers who blamed a variety of market factors for the dramatic plunge in sales volume.
One of the biggest mistakes a medical device company can make when using an independent sales force is neglecting the situation where sales representatives are disinclined to do the legwork of building up a product's market when the manufacturer is likely to sell out to a bigger company or switch to a direct sales force, according to Rick Davies, managing partner at Vector Resources.
A study claiming that two state pharmaceutical gift disclosure laws do not make payment information easily available to the public relied on inconsistent and mixed data, a top PhRMA official said.
Companies should create strong policies to monitor and regulate compliance with the Foreign Corrupt Practices Act (FCPA), as the number of cases in the healthcare industry is growing, an industry expert said.